• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊入院后降钙素原的变化对急性传染病患者的住院死亡率具有高度预测性。

Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases.

机构信息

Emergency Medicine Department, Sapienza University, Rome, Italy.

出版信息

Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:133-42.

PMID:23436675
Abstract

BACKGROUND AND AIM

To evaluate the diagnostic and prognostic usefulness of procalcitonin (PCT) in patients admitted to the Emergency Department (ED) with signs of infections and to assess the prognostic value of repeated measurements in predicting hospital mortality.

MATERIALS AND METHODS

A prospective, observational study was conducted in our 400-bed General Teaching Hospital. 261 patients arriving in ED with signs/symptoms of infection were enrolled. PCT was performed upon arrival in the ED (T0), and 5 days after antibiotic therapy (T5). Blood cultures were performed in all patients upon arrival in the ED.

RESULTS

Mean T0 PCT value was 7.1±17.9 ng/ml, and at T5 3±9.1 ng/ml (p < 0.0001). Mean PCT in septic non-survivors was increased at T5 compared to T0 but not significantly. The PCT increase at T5 was an independent factor of mortality (OR = 1.29, p < 0.02) in septic patients. Compared to baseline mean delta % PCT decrease at T5 was 28%. Patients with a decrease delta % PCT > 28% showed a lower number of deaths, with a statistical significant difference if compared to those patients with a < 28% decrease (p < 0.004). ROC curve of delta % PCT for prediction of death has an AUC = 0.82 (p < 0.03).

CONCLUSIONS

PCT is a useful marker for diagnosis of systemic and local infections, and for prognostic stratification in patients with acute infectious diseases at their arrival in ED. PCT variations after antibiotic therapy are highly predictive for in-hospital mortality. PCT normalization during antibiotic therapy suggests a good response to infection possibly leading to less infection-related deaths.

摘要

背景与目的

评估降钙素原(PCT)在因感染症状而就诊于急诊(ED)的患者中的诊断和预后价值,并评估重复测量在预测医院死亡率方面的预后价值。

材料与方法

在我们的 400 张病床的综合教学医院进行了一项前瞻性、观察性研究。共纳入 261 名因感染症状/体征而就诊于 ED 的患者。在 ED 就诊时(T0)和抗生素治疗后 5 天(T5)进行 PCT 检测。所有患者在 ED 就诊时均进行血培养。

结果

T0 时 PCT 的平均浓度为 7.1±17.9ng/ml,而在 T5 时为 3±9.1ng/ml(p<0.0001)。与 T0 相比,感染性休克非幸存者在 T5 时的 PCT 值升高,但无统计学意义。T5 时 PCT 的增加是感染性休克患者死亡的独立因素(OR=1.29,p<0.02)。与基线相比,T5 时的 delta % PCT 平均降低率为 28%。delta % PCT 降低率>28%的患者死亡率较低,与 delta % PCT 降低率<28%的患者相比差异有统计学意义(p<0.004)。delta % PCT 预测死亡的 ROC 曲线 AUC 值为 0.82(p<0.03)。

结论

PCT 是诊断全身和局部感染以及对急性感染性疾病患者进行预后分层的有用标志物。抗生素治疗后 PCT 的变化对住院死亡率具有高度预测性。抗生素治疗期间 PCT 正常化提示对感染的反应良好,可能导致与感染相关的死亡减少。

相似文献

1
Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases.急诊入院后降钙素原的变化对急性传染病患者的住院死亡率具有高度预测性。
Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:133-42.
2
The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.可溶性血栓调节蛋白在急诊科脓毒症患者危险分层和预后评估中的作用。
Thromb Res. 2013 Oct;132(4):471-6. doi: 10.1016/j.thromres.2013.08.011. Epub 2013 Aug 28.
3
Prognostic value of adrenomedullin in septic patients in the ED.急诊脓毒症患者中肾上腺髓质素的预后价值。
Am J Emerg Med. 2013 Jul;31(7):1017-21. doi: 10.1016/j.ajem.2013.03.017. Epub 2013 May 17.
4
Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.呼吸困难患者入院时和住院期间降钙素原和中肾上腺髓质素检测的 30 天和 90 天死亡率预测价值。来自 VERyfing DYspnea 试验的结果。
Am J Emerg Med. 2014 Apr;32(4):334-41. doi: 10.1016/j.ajem.2013.12.045. Epub 2014 Jan 3.
5
Evaluation of the Mortality in Emergency Department Sepsis score combined with procalcitonin in septic patients.评估急诊脓毒症评分与降钙素原联合在脓毒症患者中的死亡率。
Am J Emerg Med. 2013 Jul;31(7):1086-91. doi: 10.1016/j.ajem.2013.04.008. Epub 2013 May 20.
6
Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department.急诊科脓毒症患者中急诊科脓毒症评分、降钙素原及C反应蛋白对死亡率的预后价值
Shock. 2008 Mar;29(3):322-7. doi: 10.1097/shk.0b013e31815077ca.
7
The utility of procalcitonin in critically ill trauma patients.降钙素原在危重症创伤患者中的应用。
J Trauma Acute Care Surg. 2012 Aug;73(2):413-8; discussion 418. doi: 10.1097/TA.0b013e31825ff5b7.
8
Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department.急诊科就诊患者中白细胞计数、降钙素原和C反应蛋白作为感染或脓毒症诊断及预后生物标志物的比较
Clin Chem Lab Med. 2014 Oct;52(10):1465-72. doi: 10.1515/cclm-2014-0210.
9
The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration.半定量降钙素原检测试剂盒作为启动抗生素治疗指南的实用性。
Am J Emerg Med. 2009 Sep;27(7):859-63. doi: 10.1016/j.ajem.2008.06.021.
10
[Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].[生物标志物组合对急诊科脓毒症和严重脓毒症患者的诊断价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Mar;26(3):153-8. doi: 10.3760/cma.j.issn.2095-4352.2014.03.006.

引用本文的文献

1
Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub-analysis of the DIANA study Japanese data.重症监护病房中第7天经验性抗菌治疗的临床反应及死亡率评估:DIANA研究日本数据的亚组分析
Acute Med Surg. 2023 May 17;10(1):e842. doi: 10.1002/ams2.842. eCollection 2023 Jan-Dec.
2
Current Status of Antibiotic Stewardship and the Role of Biomarkers in Antibiotic Stewardship Programs.抗生素管理的现状及生物标志物在抗生素管理计划中的作用
Infect Chemother. 2022 Dec;54(4):674-698. doi: 10.3947/ic.2022.0172.
3
The 28-day survive for critically ill cancer patients undergoing continuous renal replacement with postoperative acute kidney injure: a retrospective study of 86 cases.
术后急性肾损伤行持续肾脏替代治疗的重症癌症患者28天生存率:86例回顾性研究
Transl Cancer Res. 2020 Oct;9(10):6221-6231. doi: 10.21037/tcr-20-1324.
4
Prognostic Role of Serum Procalcitonin Measurement in Adult Patients Admitted to the Emergency Department with Fever.血清降钙素原检测在因发热入住急诊科的成年患者中的预后作用
Antibiotics (Basel). 2021 Jun 29;10(7):788. doi: 10.3390/antibiotics10070788.
5
Should serial monitoring of procalcitonin be done routinely in critically ill patients of ICU: A systematic review and meta-analysis.在重症监护病房(ICU)的危重症患者中是否应常规进行降钙素原的连续监测:一项系统评价和荟萃分析。
J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):458-464. doi: 10.4103/joacp.JOACP_388_19. Epub 2021 Jan 18.
6
Use of Procalcitonin to Guide Discontinuation of Antimicrobial Therapy in Patients with Persistent Intra-Abdominal Collections: A Case Series.降钙素原用于指导持续性腹腔内积液患者抗菌治疗的停用:病例系列
Case Rep Infect Dis. 2020 Jan 9;2020:6342180. doi: 10.1155/2020/6342180. eCollection 2020.
7
Toddalolactone Protects Lipopolysaccharide-Induced Sepsis and Attenuates Lipopolysaccharide-Induced Inflammatory Response by Modulating HMGB1-NF-κB Translocation.托达洛内酯通过调节HMGB1-NF-κB转位保护脂多糖诱导的脓毒症并减轻脂多糖诱导的炎症反应。
Front Pharmacol. 2020 Feb 21;11:109. doi: 10.3389/fphar.2020.00109. eCollection 2020.
8
Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia.循环鞘氨醇-1-磷酸作为社区获得性肺炎的预后生物标志物。
PLoS One. 2019 May 15;14(5):e0216963. doi: 10.1371/journal.pone.0216963. eCollection 2019.
9
Combination of procalcitonin, C-reaction protein and carcinoembryonic antigens for discriminating between benign and malignant pleural effusions.降钙素原、C反应蛋白和癌胚抗原联合用于鉴别良恶性胸腔积液
Oncol Lett. 2018 Aug;16(2):1727-1735. doi: 10.3892/ol.2018.8871. Epub 2018 Jun 1.
10
Relationship of Serum Procalcitonin, C-reactive Protein, and Lactic Acid to Organ Failure and Outcome in Critically Ill Pediatric Population.危重症儿科患者血清降钙素原、C反应蛋白和乳酸与器官功能衰竭及预后的关系
Indian J Crit Care Med. 2018 Feb;22(2):91-95. doi: 10.4103/ijccm.IJCCM_4_17.